; (2) by inserting after paragraph (5) the following new paragraph: (6) No prior authorization programs for tobacco cessation drugs A State plan under this subchapter shall not require, as a condition of coverage or payment for a covered outpatient drug for which Federal financial participation is available in accordance with this section, the approval of an agent when used to promote smoking cessation, including agents approved by the Food and Drug Administration for the purposes of promoting, and when used to promote, tobacco cessation. . (3) by redesignating paragraphs (6) and (7) as paragraphs (7) and (8). (g) Comprehensive coverage of tobacco cessation coverage in private health insurance (1) No prior authorization for tobacco cessation coverage Section 2713 of the Public Health Service Act ( 42 U.S.C. 300gg–3 ) is amended by inserting after subsection (c) a new subsection: (d) No prior authorization A group health plan and a health insurance issuer offering group or individual health insurance coverage shall not impose any prior authorization requirement for tobacco cessation counseling and pharmacotherapy that has in effect a rating of A or B in the current recommendations of the United States Preventive Services Task Force. . (2) No cost sharing Section 1302(c) of the Patient Protection and Affordable Care Act ( 42 U.S.C. 18022(c) ) is amended by inserting after paragraph (1) the following new paragraph: (2) No cost sharing or prior authorization for comprehensive tobacco cessation coverage There shall be no cost sharing or prior authorization requirement imposed with respect to services described in subsection (b)(1)(K). . (h) Effective date The amendments made by this section shall apply to items and services furnished on or after January 1, 2019. 735. Clinical research funding for oral health (a) In general The Secretary of Health and Human Services shall expand and intensify the conduct and support of the research activities of the National Institutes of Health and the National Institute of Dental and